Skip to main content

Feasibility of serodiagnosis of ovarian cancer by mass spectrometry.

West-Nørager M, Bro R, Marini F, Høgdall EV, Høgdall CK, Nedergaard L, Heegaard NH

Publication: Anal Chem (2009) • Vol 81 • Page 1907-13PMID: 19178286View on PubMed

Purpose

The purpose of this paper was to determine the effects of patient age, frozen storage duration, and diagnosis on MALDI-TOF mass spectrometry (MS) peak patterns in serum.

Conclusion

The authors report no patient-age dependent correlations in MALDI-TOF MS data. Duration of serum storage up to 15 months could be predicted with some degree of confidence based on peak patterns, but there was more uncertainty beyond 15 months.

Studies (1)

Purpose

The purpose of this study was to determine the effects of patient age, frozen storage duration, and diagnosis of malignant versus benign ovarian tumor on the MALDI-TOF MS peak patterns in serum. Serum was stored at -80 degrees C within 6 h of blood collection.

Summary of Findings

The authors report no patient-age dependent correlations in MALDI-TOF MS data. Duration of serum storage up to 15 months could be predicted with some degree of confidence based on peak patterns, but there was more uncertainty beyond 15 months. The authors were able to develop a model to differentiate serum MALDI-TOF MS peak patterns from patients with benign versus malignant ovarian tumors, but it did not perform as well as existing serum markers.

  • Biospecimens

    FluidSerum
    FluidBlood
  • Preservation Types

    Frozen
  • Diagnoses

    NeoplasticBenign
    NeoplasticCarcinoma
  • Platforms

    ProteinMALDI-TOF MS
    PeptideMALDI-TOF MS
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Benign
    Ovarian cancer
    PreaquisitionPatient age
    Mean 45 years
    Mean 65 years
    StorageStorage duration
    1-23 months